The DOI matches its Crossref record; 192 of the 198 references it cites were found in a registry or an index.
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Open accessAbstract
homeostasis, autophagy, the release of nitric oxide and inflammatory mediators and altered gene and protein expression that involved apoptosis. Dox also causes downregulation of DNA methyltransferase 1 (DNMT1) enzyme activity which leads to a reduction in the DNA methylation process. This hypomethylation causes dysregulation in the mitochondrial genes like peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1-alpha (PGC-1α), nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (TFAM) unit in the heart. Apart from DNA methylation, Dox treatment also alters the micro RNAs levels and histone deacetylase (HDAC) activity. Therefore, in the current review, we have provided a detailed update on the current understanding of the pathological mechanisms behind the well-known Dox-induced cardiotoxicity. Further, we have provided some of the most plausible pharmacological strategies which have been tested against Dox-induced cardiotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cumulative anthracycline dose is a major risk factor for severe cardiomyopathy development but young age at treatment, female sex, peak drug exposure and additional stress to the heart have also been implicated 161,162,163 .”
From Osteosarcoma (2022) · cites this paper as [163]
Citations
Cites
2 retracted
Suliman, H. B., Carraway, M. S., Ali, A. S., Reynolds, C. M., Welty‐Wolf, K. E., & Piantadosi, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32967 · Cited by 261
RetractedChoi, H. C., Song, P., Xie, Z., Wu, Y., Xu, J., Zhang, M., Dong, Y., Wang, S., Lau, K., & Zou, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803020200 · Cited by 85
RetractedAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
The ENCODE (ENCyclopedia Of DNA Elements) Project
(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G. C., Antosiewicz‐Bourget, J., O’Malley, R. C., Castanon, R., Klugman, S. A., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,595
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425
Nitric Oxide Synthases: Properties and Catalytic Mechanism
Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881
Research works printed but not linked: 6
- Gianni, 2008, Anthracycline cardiotoxicity: from bench to bedside, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 26, 3777, 10.1200/JCO.2007.14.9401 · DOI
- Chustecka, 2006, Cardiotoxicity of imatinib is a" surprise, Nat. Med., 24
- Martínez-Mateo, 2017, Report of cisplatin-induced cardiotoxicity: a side effect to monitor closely, J. Heart Health, 3
- Speth, 1988, Clinical pharmacokinetics of doxorubicin, Clin. Pharmacokinet., 15, 15, 10.2165/00003088-198815010-00002 · DOI
- Youngson, 2006, Collins dictionary of human biology, Collins
- Zhu, 2009, Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mTOR pathway, Circulation, 119, 99, 10.1161/CIRCULATIONAHA.108.799700 · DOI
Cited by
Sorted by citations
Items 201–300 of 915
Different Mechanisms in Doxorubicin-Induced Neurotoxicity: Impact of BRCA Mutations
Bhatt, K. S., Singh, A., Marwaha, G. S., Ravendranathan, N., Sandhu, I. S., Kim, K., Singh, E., Frisbee, J. C., & Singh, K. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104736 · Cited by 18
van der Geest, J. S. A., Kelters, I. R., Arends, B. K. O., van Ham, W. B., Benavente, E. D., Lapré, T. A., van der Kraak, P. H., van der Harst, P., Teske, A. J., Dendorfer, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70085 · Cited by 17
Cardiolipin nanodisks confer protection against doxorubicin-induced mitochondrial dysfunction
Fox, C. A., Romenskaia, I., Dagda, R. K., & Ryan, R. O. (2022) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2022.183984 · Cited by 17
Artyukhov, A. A., Nechaeva, A. M., Shtilman, M. I., Chistyakov, E. M., Svistunova, А. Y., Bagrov, D. V., Николаевич, К. А., Docea, A. O., Tsatsakis, A. M., Gurevich, L., et al. (2022) · Materials · doi:10.3390/ma15207136 · Cited by 17
Juszczak, M., Das, S., Kosińska, A., Rybarczyk‐Pirek, A. J., Wzgarda‐Raj, K., Tokarz, P., Vasudevan, S., Chworoś, A., Woźniak, K., & Rudolf, B. (2023) · Dalton Transactions · doi:10.1039/d2dt04083b · Cited by 17
New insights in aptamer-targeted nanoliposomes for the treatment of breast cancer
Singhai, N. J., Maheshwari, R., & Khatri, K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104880 · Cited by 17
Intracellular Trafficking of Size-Tuned Nanoparticles for Drug Delivery
Gimondi, S., Ferreira, H., Reis, R. L., & Neves, N. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010312 · Cited by 17
Metal–Organic Frameworks-Based Nanoplatform for Treatment of Breast Cancer
Li, Y., Sun, H., Yang, C., Yan, Z., Ge, J., Wang, J., Chen, Z., Qiu, L., & Bai, Y. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c00984 · Cited by 17
Early detection of anthracycline-induced cardiotoxicity
Feng, W., Wang, Q., Tan, Y., Qiao, J., Liu, Q., Yang, B., Yang, S., & Cui, Y. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120000 · Cited by 17
He, J., Xue, W., & Li, Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s560983 · Cited by 16
Liu, X., Dhumal, D. M., Santofimia‐Castaño, P., Liu, J., Casanova, M., Garcia-Muñoz, A. C., Perles‐Barbacaru, T., Elkihel, A., Zhang, W., Roussel, T., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu9948 · Cited by 16
The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia
da Mota, T. H. A., Camargo, R., Biojone, E. R., Guimarães, A. F. R., Pittella-Silva, F., & de Oliveira, D. M. (2023) · Genes · doi:10.3390/genes14030691 · Cited by 16
Zhu, H., He, M. Y., Wang, Y., Zhang, Y., Dong, J., Chen, B., Li, Y., Zhou, L., Du, L., Liu, Y., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10570 · Cited by 16
Aghdam, K. J., Sabeti, B., Chekin, F., & Mashreghi, M. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207326666230821145508 · Cited by 16
Jeong, Y., Lee, S., Lee, J., Kim, M., Lee, Y. G., Hwang, J., Choi, S. Y., Yoon, H., Lim, T., Lee, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115912 · Cited by 16
Zhang, P., Liu, Y., Zhan, Y., Zou, P., Cai, X., Chen, Y., & Shao, L. (2024) · Epigenetics · doi:10.1080/15592294.2024.2380145 · Cited by 16
Iron metabolism in doxorubicin-induced cardiotoxicity: From mechanisms to therapies
Ye, H., Wu, L., & Liu, Y. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106632 · Cited by 20
Negm, A., Mersal, E. A., Dawood, A. F., El‐Azim, A. O. A., Hasan, O., Alaqidi, R., Alotaibi, A., Alshahrani, M., Alheraiz, A., & Shawky, T. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073201 · Cited by 16
Kanno, S., & Hara, A. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09726-w · Cited by 16
Nechaeva, A. M., Artyukhov, A. A., Luss, A. L., Shtilman, M., Gritskova, I. A., Shulgin, A. M., Motyakin, M. V., Levina, I. I., Krivoborodov, E. G., Toropygin, I. Y., et al. (2022) · Polymers · doi:10.3390/polym14091727 · Cited by 16
Epigenetic Mechanisms Governing Nrf2 Expression and Its Role in Ferroptosis
Li, L., Liu, X., Si, Z., & Wang, X. (2025) · Biomedicines · doi:10.3390/biomedicines13081913 · Cited by 18
Lu, Y., Min, Q., Zhao, X., Li, L., Zhao, G., & Dong, J. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04769-1 · Cited by 15
Lady’s Bedstraw as a Powerful Antioxidant for Attenuation of Doxorubicin-Induced Cardiotoxicity
Bradić, J., Andjic, M. M., Novakovic, J. N., Kočović, A. G., Tomovic, M. T., Petrović, A., Nikolic, M. R., Mitrović, S., Jakovljevic, V. L., & Pecarski, D. (2023) · Antioxidants · doi:10.3390/antiox12061277 · Cited by 15
Li, X., Sun, T., Liu, J., Wei, S., Yang, Y., Liu, J., Zhang, B., & Li, W. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155046 · Cited by 15
Hanan, E., Hasan, N., Zahiruddin, S., Ahmad, S., Sharma, V., & Ahmad, F. J. (2023) · ACS Omega · doi:10.1021/acsomega.3c00698 · Cited by 15
Guo, X., Liu, M., Han, B., Zheng, Y., Zhang, K., Bao, G., Gao, C., Shi, H., Sun, Q., & Zhao, Z. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.116009 · Cited by 15
Arab, H. H., Eid, A. H., Alsufyani, S. E., Ashour, A. M., Alnefaie, A. M., Al-Sharif, N., Alshehri, A. M., Almalawi, A. A., Alsowat, A. A., Aal, H. A. A. E., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17060681 · Cited by 15
Qaed, E., Almoiliqy, M., Liu, W., Al-mashriqi, H. S., Alyafeai, E., Aldahmash, W., Mahyoub, M. A., & Tang, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113677 · Cited by 15
Nanozyme-based synergistic therapeutic strategies against tumors
Zhang, Y., Zhang, N., Gong, S., Chen, Z., & Cao, H. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104292 · Cited by 15
Regulators of epigenetic change in ferroptosis‑associated cancer (Review)
Wu, J., Zhu, S., Wang, P., Wang, J., Huang, J., Wang, T., Guo, L., Liang, D., Meng, Q., & Pan, H. (2022) · Oncology Reports · doi:10.3892/or.2022.8430 · Cited by 16
Vascular Toxicities of Cancer Therapies: 2025 Update
Donisan, T., Balanescu, D. V., Abe, J., Lerman, A., Iliescu, C., & Herrmann, J. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.319867 · Cited by 14
Mochizuki, T., Ikegami, M., & Akiyama, T. (2023) · Cancer Science · doi:10.1111/cas.16050 · Cited by 14
Imam, R. A., Aboulhoda, B. E., Amer, M. M., Hassan, F. E.-S., Alghamdi, M. A., & Abdel-Hamed, M. R. (2024) · Microscopy Research and Technique · doi:10.1002/jemt.24544 · Cited by 14
The NEDD8 activating enzyme inhibitor MLN4924 mitigates doxorubicin-induced cardiotoxicity in mice
Chen, K. H., Sun, J. M., Lin, L., Liu, J. W., Liu, X. Y., Chen, G. D., Chen, H., & Chen, Z. Y. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.04.221 · Cited by 14
Serini, S., & Calviello, G. (2024) · Antioxidants · doi:10.3390/antiox13040486 · Cited by 14
Na, H., Carrier, J., Oyon, S. A., & Lai, C. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00291 · Cited by 14
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Matusik, K., Kamińska, K., Sobiborowicz, A., Borzuta, H., Buczma, K., & Cudnoch‐Jędrzejewska, A. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10414-w · Cited by 14
Kansu, G., Öztürk, N., Karağaç, M. S., Yeşilkent, E. N., & Ceylan, H. (2024) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2648 · Cited by 14
Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
Todorova, V. K., Azhar, G., Stone, A., Malapati, S. J., Che, Y., Zhang, W., Makhoul, I., & Wei, J. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179735 · Cited by 16
Pal, C. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09941-7 · Cited by 14
Nutrition Modulation of Cardiotoxicity in Breast Cancer: A Scoping Review
Stephenson, E., Mclaughlin, M., Bray, J., Saxton, J., & Vince, R. V. (2024) · Nutrients · doi:10.3390/nu16213777 · Cited by 14
Chen, Y., Ma, L., Yan, Y., Wang, X., Cao, L., Li, Y., & Li, M. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13401 · Cited by 14
Asiwe, J. N., Yovwin, G. D., Alawode, M. O., Isola, T., Umukoro, E. K., Igbokwe, V. U., & Asiwe, N. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03650-2 · Cited by 15
Xu, Q. Y., Wang, X., Hu, J., Wang, Y., Lü, S., Xiong, J., Li, H., Xiong, N., Huang, Y., Wang, Y., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.021 · Cited by 13
Shang, W. H., Li, X., Zeng, L.-H., Li, Z., Hu, Y., Wen, H.-M., Cao, F., & Wan, G. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s535517 · Cited by 13
Saeed, H. A., Ali, N. A. M., & Othman, R. T. (2025) · Cardio-Oncology · doi:10.1186/s40959-025-00386-7 · Cited by 13
Anti-Leukemic Activity of Brassica-Derived Bioactive Compounds in HL-60 Myeloid Leukemia Cells
Núñez‐Sánchez, M. Á., Martínez‐Sánchez, M. A., Verdejo-Sánchez, M., García-Ibáñez, P., Oliva‐Bolarín, A., Ramos‐Molina, B., Moreno, D. A., & Ruiz‐Alcaraz, A. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113400 · Cited by 13
Targeting the Na+/K+ ATPase DR-region with DR-Ab improves doxorubicin-induced cardiotoxicity
Leng, B., Deng, L., Tan, J., Lee, W.-T., Cao, C.-R., Wang, Z., Huang, D., Nie, X., & Bian, J. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.04.008 · Cited by 13
Recent advances in marine oligosaccharides: A review of bioactivities and application
Luan, T., Hu, S. J., Nie, W., Liu, J., Wang, S., Li, J., Zhou, J., An, N., Wang, Y., Cui, Z., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105754 · Cited by 13
Malathi, S., Sisila, V., Singaravel, V., Venkatesan, N., Pakrudheen, I., Dhanaraj, R. K., Ayyadurai, N., Bhuvarahamurthy, V., & Kalkura, S. N. (2023) · Materials Advances · doi:10.1039/d3ma00328k · Cited by 13
Yang, Y., Zhao, C.-Z., Zhao, C., Wen, Z.-Y., Ma, Y.-Y., Zhao, X.-N., Wang, L., Huang, J.-L., & Zhou, P. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae005 · Cited by 13
Tian, G., Li, J., Wang, W., & Zhou, L. (2024) · Drug Development Research · doi:10.1002/ddr.22149 · Cited by 13
Manawy, S., Faruk, E. M., Hindawy, R. F., Hassan, M. M. A., Farrag, D. M. G., Bashar, M. A. E., Fouad, H. H., Bagabir, R. A., Hassan, D. A. A., Zaazaa, A. M., et al. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102330 · Cited by 13
Zhang, B., Li, Y., Liu, N., & Liu, B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300261 · Cited by 13
El-Sawy, W. S. M., El‐Bahrawy, A. H., Messiha, B. A. S., Hemeida, R. A. M., & Khalaf, M. M. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114863 · Cited by 13
Mohamed, A. T. A. E., Mohamed, A. T. A. E., Ragheb, M. A., & Shehata, M. R. (2024) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2024.127516 · Cited by 13
Liu, J., Xin, Y., Qiu, Z., Zhang, Q., He, T., Qiu, Y., & Wang, W. (2022) · RSC Advances · doi:10.1039/d2ra01470j · Cited by 13
Morsy, M. A., Abdel-Gaber, S. A., Mokhemer, S. A., Kandeel, M. K., Sedik, W. F., Nair, A. B., Venugopala, K. N., Khalil, H. E., Al‐Dhubiab, B. E., & Mohamed, M. Z. (2023) · Pharmaceuticals · doi:10.3390/ph16050665 · Cited by 13
Sun, J., Zhou, J., Sun, S., Lin, H., Zhang, H., Zhong, Z., Chi, J., & Guo, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-28437-y · Cited by 12
Nanomedicines Based on Responsive Nanocarriers for Cancer Therapy
Liu, Z., Wen, J., Huang, C., Zhang, P., Miao, Y., Cheng, H. B., & Li, S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300223 · Cited by 12
Oyovwi, M. O., Faith, F. Y., Ejiro, O. P., Uchechukwu, J. G., Olowe, G. T., Oghenetega, O. B., Emojevwe, V. O., Edesiri, T. P., Rotu, R. A., Rotu, R. A., et al. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100111 · Cited by 12
Mesenchymal Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Cardiotoxicity
Ali, S. A., & Singla, D. K. (2024) · Pharmaceuticals · doi:10.3390/ph17010093 · Cited by 12
Stepanović, A., Terzić, N., Korać, A., Zlatović, M. V., Nikolić, I., Opsenica, I., & Pešić, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116496 · Cited by 12
Lu, L., Shao, Y., Wang, N., Xiong, X., Zhai, M., Tang, J., Yang, L., Yang, J., & Yang, L. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04955-9 · Cited by 12
Mohsin, S., Hasan, M., Sheikh, Z. M., Mustafa, F., Tegeltija, V., Kumar, S., & Kumar, J. (2024) · Future Cardiology · doi:10.1080/14796678.2024.2363673 · Cited by 12
Hwang, J., Park, J. Y., Kang, J., Oh, N., Li, C., Yoo, C., Um, W., & Kwak, M. (2024) · Macromolecular Rapid Communications · doi:10.1002/marc.202400480 · Cited by 12
Zheng, Y., Xiang, G., Zeng, L., Yang, C., Ke, J., Yu, H., & Zhang, J. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111407 · Cited by 12
Juszczak, M., Tokarz, P., & Woźniak, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910257 · Cited by 12
Li, D., Chen, Y., Zhang, B., Heng, X., Yin, J., Zhao, P., Sun, N., & Shao, C. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117108 · Cited by 12
Kelly, C., Kiltschewskij, D. J., Leong, A. J. W., Haw, T. J., Croft, A. J., Balachandran, L., Chen, D., Bond, D. R., Lee, H. J., Cairns, M. J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-87442-5 · Cited by 12
Spermine alleviates myocardial cell aging by inhibiting mitochondrial oxidative stress damage
Yang, J., Zhang, C., Li, Z., Gao, Y.-H., Jiang, L., Zhang, J., Wang, P., & Liu, T. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177477 · Cited by 13
Rajpoot, A., & Sharma, V. (2025) · Heart and Mind · doi:10.4103/hm.hm-d-24-00148 · Cited by 13
Alrohaimi, A. H., Mostafa, M. A. H., Alnour, T. M. S., Alghamdi, S., AlMuraikhi, N. A., Mirdad, D. S. A., Alghamdi, H., & Senbel, A. M. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002702 · Cited by 12
Koczurkiewicz, P., Gąsiorkiewicz, B., Piska, K., Gunia‐Krzyżak, A., Jamrozik, M., Bucki, A., Słoczyńska, K., Bojdo, P., Wójcik‐Pszczoła, K., Władyka, B., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120777 · Cited by 12
Wang, T., Yuan, C., Liu, J., Deng, L., Li, W., He, J., Liu, H., Qu, L., Wu, J., & Zou, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020897 · Cited by 12
Sun, L., Ma, B., Zuo, C., Liu, X., Xia, Y., Wang, X., Guo, Y., & Han, M. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104442 · Cited by 12
CTRP5 Attenuates Doxorubicin-Induced Cardiotoxicity Via Inhibiting TLR4/NLRP3 Signaling
Zhang, Z., Peng, J., Hu, Y., Zeng, G., Du, W., & Shen, C. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07464-x · Cited by 12
Lee, E. J., Jang, W. B., Choi, J., Lim, H. J., Park, S., Rethineswaran, V. K., Ha, J. S., Yun, J., Hong, Y. J., Choi, Y. J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512070 · Cited by 12
Medjahed, Z., Chaher, N., Atmani-Kilani, D., Ahmane, N., Ruiz‐Larrea, M. B., Ruiz-Sanz, J. I., Charid, I., Amant, F. C., Valls, J., Saidène, N., et al. (2023) · Fitoterapia · doi:10.1016/j.fitote.2023.105642 · Cited by 12
Yarmohammadi, F., Hesari, M., & Shackebaei, D. (2023) · Cardiovascular Toxicology · doi:10.1007/s12012-023-09820-7 · Cited by 12
Drug delivery with Mn‐doped MoO 2 for photothermal‐enhanced chemotherapy in fighting cancers
Zhao, P., Zheng, H. L., Peng, J., Li, X., Raziq, F., Liu, X., Yu, H., Tang, J., Kang, Y., & Huang, W. (2024) · Rare Metals · doi:10.1007/s12598-023-02568-7 · Cited by 12
Expanding roles of circRNAs in cardiovascular diseases
Liu, X., Yao, X., & Chen, L. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.02.001 · Cited by 12
Mesoporous Organosilica-Based Hydrogen Sulfide Nanogenerator for Enhanced Tumor Chemotherapy
Xu, J. F., Zhu, W., Yao, X., Mai, S., Li, C., Zhang, M., Shu, D., & Yang, W. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c01824 · Cited by 11
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Basal, O. A., Zahran, R. F. K., & Saad, E. A. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00403-z · Cited by 11
Xiong, D.-Q., Yang, J., Li, D., & Wang, J. (2023) · Cardiovascular Toxicology · doi:10.1007/s12012-023-09806-5 · Cited by 11
Kondo, M., Nakamura, Y., Kato, Y., Nishimura, A., Fukata, M., Moriyama, S., Ito, T., Umezawa, K., Urano, Y., Akaike, T., et al. (2024) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2024.07.007 · Cited by 12
Tohidi, M., Allahyari, A., Azimi, S. A., Alimi, H., Elyasi, S., Seraj, F. Q. M., & Mehrad‐Majd, H. (2024) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552241277958 · Cited by 11
Wu, H., Zhao, G., Feng, W., Yang, C., & Jiang, Y. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111391 · Cited by 11
Vericiguat Improves Cardiac Remodelling and Function in Rats with Doxorubicin-Induced Cardiomyopathy
Chen, W., Wu, Y., Li, J., Song, M., Xu, K., Wu, M., & Lin, L. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15186 · Cited by 11
Wang, F., Wang, K., Fang, B., Geng, S., Li, Y., Qian, H., Lin, Y., & Yu, Z. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.02.033 · Cited by 11
Sensor-integrated gut-on-a-chip for monitoring senescence-mediated changes in the intestinal barrier
Brandauer, K., Lorenz, A., Schobesberger, S., Schuller, P., Frauenlob, M., Spitz, S., & Ertl, P. (2025) · Lab on a Chip · doi:10.1039/d4lc00896k · Cited by 11
Alshaer, W., Lafi, Z., Nsairat, H., AlQuaissi, B., Alqudah, D. A., Zureigat, H., & Hamad, I. M. (2025) · Molecules · doi:10.3390/molecules30071549 · Cited by 11
Nan, A., Dumitraşcu, V., Flangea, C., Dumitrescu, G., Puscasiu, D. A., Vlad, T., Popescu, R., & Vlad, C. S. (2025) · Nutrients · doi:10.3390/nu17091595 · Cited by 11
Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity
Nsairat, H., Lafi, Z., Abualsoud, B. M., Al-Najjar, B. O., Al-Samydai, A. M., Oriquat, G. A., Alshaer, W., Ibrahim, A. A., & Dellinger, A. L. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.042534 · Cited by 12
Progress on the efficacy and mechanism of action of panax ginseng monomer saponins treat toxicity
Wang, X.-Y., Rongcan, W. A. N. G., Yong-Fei, Q. I. A. O., & Li, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1022266 · Cited by 11
Seaweed Sargassum aquifolium extract ameliorates cardiotoxicity induced by doxorubicin in rats
Samir, R., Hassan, E. A., Saber, A. A., Haneen, D. S. A., & Saleh, E. M. R. M. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-26259-z · Cited by 14
Wang, W., Yu, Y., Chen, H., Sun, P., Lu, L., Yan, S., 刘训红, Lu, T., Li, W., Lu, T., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116724 · Cited by 11
Ferreira, R. C., Duarte, S. S., de Sousa, V. M., de Souza, R. R. M., Marques, K. K. G., de Abrantes, R. A., do Nascimento, Y. M., de Sousa, N. F., Scotti, M. T., Scotti, L., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16111553 · Cited by 13
Different Mechanisms in Doxorubicin-Induced Cardiomyopathy: Impact of BRCA1 and BRCA2 Mutations
Nguyen, H. C., Frisbee, J. C., & Singh, K. K. (2024) · Hearts · doi:10.3390/hearts5010005 · Cited by 11
Metadata
- Authors
- Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U.
- Affiliations
- Central University of Punjab (IN)
- P.V. Narsimha Rao Telangana Veterinary University (IN)
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 139
- Pages
- 111708
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W3160992829
- Cited by
- 909
- References
- 198
- Citations by year
- 2026: 171 · 2025: 232 · 2024: 208 · 2023: 193 · 2022: 92 · 2021: 13
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Royal Society of Medicine
- University of Central Punjab (GP-25)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- doxorubicin, cardiotoxicity, molecular mechanisms, DNA methylation, DNMT1, mitochondrial dysfunction, PGC-1α, NRF1, TFAM, microRNA, histone deacetylase, autophagy, apoptosis, nitric oxide, inflammatory mediators, cardioprotection, anthracycline chemotherapy
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Doxorubicin, Humans, Mitochondria, Heart, Apoptosis, Oxidative Stress, Cardiotoxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review